Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2026)
Krystal Biotech recorded quarterly Exchange Rate Effect of -$1.3 million in Q1 2026, down 108.95% quarter-over-quarter from -$637000.0 in Q4 2025, and down 878.36% year-over-year from $171000.0 in Q1 2025.
Krystal Biotech's Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 878.36% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$1.2 million (down 156.54% YoY), while the FY2025 annual figure was $286000.0, up 162.45% from the prior year.
- Exchange Rate Effect came in at -$1.3 million for Q1 2026 at Krystal Biotech, down from -$637000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q2 2025 to a low of -$1.3 million in Q1 2026.
- A 5-year average of -$121428.6 and a median of -$38500.0 in 2022 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 2283.33% in 2024 and fell as far as 4312.5% in 2024.
- Krystal Biotech's Exchange Rate Effect stood at -$41000.0 in 2022, then tumbled by 241.46% to -$140000.0 in 2023, then plunged by 324.29% to -$594000.0 in 2024, then dropped by 7.24% to -$637000.0 in 2025, then plunged by 108.95% to -$1.3 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1.3 million, -$637000.0, and -$307000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | -1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Dec 31, 2025 | -637,000.00 |
| Dec 31, 2025 | -637,000.00 |
| Sep 30, 2025 | -307,000.00 |
| Sep 30, 2025 | -307,000.00 |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 171,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Dec 31, 2024 | -594,000.00 |
| Dec 31, 2024 | -594,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | -337,000.00 |
| Jun 30, 2024 | -337,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | -36,000.00 |
| Mar 31, 2023 | -36,000.00 |
| Dec 31, 2022 | -41,000.00 |
| Dec 31, 2022 | -41,000.00 |